extracorporeal photochemotherapy

extracorporeal photochemotherapy

The exposure of blood that is temporarily removed from the body to ultraviolet A radiation. This is used to treat several diseases, including pemphigus vulgaris and cutaneous T cell lymphoma.

CAUTION!

Patients exposed to photosensitizing agents, such as psoralens in conjunction with ultraviolet light, have an increased risk of melanoma and squamous cell carcinoma. They should be examined regularly so that any developing skin cancers will be detected early.
References in periodicals archive ?
Patient was treated with PUVA and later with extracorporeal photochemotherapy (ECP).
Extracorporeal photochemotherapy in cutaneous T-cell lymphoma.
Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy. Bone Marrow Transplantation, 31(4), 291-294.
Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease.
Contract notice: Supply and service of a treatment system ( fotoinattivazione ) for extracorporeal photochemotherapy .
Other treatment modalities that have been tried include photochemotherapy, methotrexate, topical calcipotriol, keratolytics, cyclosporine, azathioprine, fumaric acid esters, extracorporeal photochemotherapy and tumor necrosis factor alpha antagonists i.e.
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.
Object is the expectation of the delivery service of a system for extracorporeal photochemotherapy and everything needed for the irradiation of mononuceate cells with UV-A rays in the presence of 8-MOPP (inclusive of irradiator and disposable kits) and reinfusion of the cell concentrate patient undergoing radiation and the supply of consumables and support tecnica.
Building contracts divided into two parts deliveries are 1) three pieces of therapeutic separators intended for routine diagnosis of extracorporeal photochemotherapy and preparation of mononuclear cells to anti-tumor vaccines2) 1 piece separator for donor interventions - the separation of platelets deleucotized in line at a centrifugal separation procedure.
Building contracts divided into two parts deliveries are:1) three pieces of therapeutic separators intended for routine diagnosis for extracorporeal photochemotherapy and preparation of mononuclear cells in a cancer vaccine;2) 1 piece separator for donor interventions - the separation of platelets deleucotized in line at a centrifugal separation procedure.Estimated cost excluding VAT: 4,970,000 CZK Of the contractDivision into lots: yes
Contract award: acquisition and maintenance of medical devices photopheresis (extracorporeal photochemotherapy) and provision of associated consumables

Full browser ?